Safety of PDT-Photofrin® Prior to Lung Surgery

• Status: Completed
• Trial end date: 2019-03-22

Summary

This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.

• Phase: Phase 1

Details

• Lead Sponsor: Concordia Laboratories Inc.
• Treatments: Dihematoporphyrin Ether; Hematoporphyrin Derivative; Trioxsalen